Insmed Incorporated (INSM) Stock Analysis

Insmed Incorporated (INSM) Stock Analysis — AI Research | MarketCI

INSM

Market Closed

Insmed Incorporated

NASDAQHealthcare Biotechnology

1.27K employees

CEO: William H. Lewis

Founded: 2000

$95.80

+$0.00(+NaN%)

Market Cap

20.76B

Beta

0.77

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

INSM Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for INSM built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

28.57%

Score

2/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$190.46

AI Price Target

Machine learning • Price prediction

$76.52

Market Sentiment

News & social media analysis

0.11

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

5.35

Quality Score

Financial strength rating

4.00

AI Investment Grade

Deep analysis of filings & news

48.00

Key Investment Highlights

Important factors affecting INSM investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

47.37% Poor

Conditions Met

18.00/38.00

Due Diligence Score

47.37%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Fail
	Fail
	Pass
	Pass

Showing 1 to 6 of 46 conditions